UnitedHealthcare (UHC) is the largest private health insurer in the United States, covering more than 50 million members. Their pharmacy benefits are managed through OptumRx, which means your GLP-1 coverage is determined by OptumRx formulary decisions as much as by UHC medical policies. Understanding both sides of that equation is essential for getting your medication covered.
Quick Answer
UnitedHealthcare covers Ozempic for type 2 diabetes on most plans. For weight-loss indications, UHC has been expanding coverage but maintains strict prior authorization and step therapy requirements. Wegovy and Zepbound are available on many employer-sponsored plans. Foundayo is being added to select formularies in 2026. OptumRx manages the formulary, and preferred vs. non-preferred status significantly impacts your copay.
Understanding the OptumRx Formulary
OptumRx maintains several formulary tiers that directly affect what you pay:
| Tier | Description | Typical Copay Range |
|---|---|---|
| Tier 1 | Generic drugs | $5–$20 |
| Tier 2 | Preferred brand drugs | $30–$75 |
| Tier 3 | Non-preferred brand drugs | $75–$200 |
| Tier 4 | Specialty drugs | 20–33% coinsurance |
Where a GLP-1 falls on this tier structure determines your real-world cost. OptumRx negotiates rebates with manufacturers, and these negotiations determine preferred status. In 2026, the competitive landscape between Novo Nordisk and Eli Lilly means preferred status can shift.
GLP-1 Coverage Details on UHC
| Medication | Indication | OptumRx Formulary Status (2026) | Prior Auth | Step Therapy |
|---|---|---|---|---|
| Ozempic | Type 2 Diabetes | Preferred brand (Tier 2) on most plans | Yes | Metformin first |
| Mounjaro | Type 2 Diabetes | Preferred or Non-preferred (varies) | Yes | Metformin first |
| Wegovy | Weight Management | Non-preferred brand (Tier 3) or Specialty | Yes | Lifestyle + sometimes prior AOM |
| Zepbound | Weight Management | Preferred or Non-preferred (varies by plan) | Yes | Lifestyle + sometimes prior AOM |
| Foundayo | Weight Management / T2D | Being added to select formularies | Yes | Varies |
| Rybelsus | Type 2 Diabetes | Non-preferred brand on most plans | Yes | Metformin first |
Preferred Drug Advantage
The difference between preferred and non-preferred status on UHC can mean $50–$150 per month in copay differences. If your physician prescribes a non-preferred GLP-1, ask whether a preferred alternative would be clinically appropriate. In some cases, switching to the plan's preferred option saves significant money without sacrificing efficacy.
Coverage Criteria for Weight-Loss GLP-1s
UHC's criteria for weight-management GLP-1s follow industry patterns but have some UHC-specific nuances:
Clinical Criteria
- BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity
- Documented participation in a structured weight-management program for at least 6 months within the prior 24 months
- Prescription by an appropriate healthcare provider (physician, NP, or PA)
- No concurrent use of another GLP-1 receptor agonist or dual GIP/GLP-1 agonist for the same indication
UHC-Specific Requirements
- Some UHC plans require that the prescribing provider be in-network
- Certain employer plans require the prescription to be filled through OptumRx mail-order for specialty medications
- Quantity limits apply: typically one pen/carton per 28-day supply
- Renewal requires documentation of continued weight loss or weight maintenance — some plans require at least 5% weight loss in the first 6 months
Step Therapy on UHC
UHC step therapy for GLP-1s can be more structured than other insurers:
For Type 2 Diabetes
- Step 1: Metformin (usually 90 days minimum)
- Step 2: Second-line agent (sulfonylurea, SGLT2 inhibitor, or DPP-4 inhibitor)
- Step 3: GLP-1 agonist or dual GIP/GLP-1 agonist
For Weight Management
- Step 1: 6 months documented lifestyle modifications
- Step 2: Some plans require trial of a non-GLP-1 AOM (phentermine, naltrexone/bupropion, or orlistat)
- Step 3: GLP-1 agonist
Step therapy exceptions can be requested if there are clinical contraindications to the required earlier steps. Your physician must document why the standard sequence is inappropriate for your specific situation.
Prior Authorization Process
UHC's PA process through OptumRx follows this timeline:
- Submission: Physician submits via OptumRx provider portal, CoverMyMeds, or fax
- Initial review: 3–10 business days for standard requests; 24–72 hours for urgent requests
- Decision: Approval, denial, or request for additional information
- If approved: Valid for 6–12 months depending on the plan and medication
Common Reasons for Denial
- Incomplete documentation (missing BMI, labs, or weight-management history)
- Step therapy not completed
- Plan does not include AOM benefit (employer opted out)
- Off-label use (e.g., prescribing Ozempic for weight loss instead of Wegovy)
- BMI does not meet threshold requirements
Appeals Process
UHC provides a structured appeals process:
Internal Appeal
- File within 180 days of denial notice
- Submit through the UHC member portal, by mail, or by phone
- Include a comprehensive letter of medical necessity
- Attach all supporting clinical documentation
- Decision within 30 days (15 days for urgent pre-service appeals)
External Review
- Available after exhausting internal appeals
- Independent reviewer examines the case
- Binding decision on UHC
- Particularly effective when clinical guidelines support the prescription
Peer-to-Peer
Physicians can request a peer-to-peer call with an OptumRx or UHC medical director. This is often the highest-yield intervention. Prepare for the call with specific patient history, clinical rationale, and guideline citations.
Cost Comparison on UHC Plans
| Medication | Preferred Tier Copay | Non-Preferred Copay | Specialty Tier | No Coverage (Cash) |
|---|---|---|---|---|
| Ozempic | $30–$65 | $75–$150 | N/A (usually brand tier) | $935–$1,050 |
| Wegovy | $50–$100 | $100–$250 | 20–33% coinsurance | $1,300–$1,350 |
| Zepbound | $50–$100 | $100–$250 | 20–33% coinsurance | $1,060–$1,100 |
| Foundayo | $25–$60 | $60–$125 | N/A (oral, usually brand tier) | $149–$299 |
OptumRx Mail-Order Advantage
UHC members using OptumRx mail-order pharmacy can often get a 90-day supply for the price of two copays, which effectively gives you a 33% discount. For a medication you will take long-term, this adds up. Check whether your plan requires mail-order for specialty medications — some do, and using a retail pharmacy may result in higher costs or denial.
Tips for Getting Approved on UHC
- Check the OptumRx formulary before your appointment: Search at optumrx.com to see which GLP-1s are preferred on your plan
- Ask for the preferred option: If Zepbound is preferred over Wegovy on your plan (or vice versa), choosing the preferred option saves money
- Document everything early: Start documenting weight-management attempts before you need the PA
- Use in-network providers: Out-of-network prescriptions face higher barriers
- Consider Foundayo: Its lower list price and oral formulation may place it on a more favorable tier
- Stack manufacturer savings: Copay cards from Novo Nordisk and Eli Lilly work alongside UHC coverage
Bottom Line
UnitedHealthcare GLP-1 coverage in 2026 is improving but varies by employer benefit design. OptumRx formulary position matters enormously for your out-of-pocket cost. Prior authorization is universal, step therapy is common, and the preferred/non-preferred distinction can mean the difference between an affordable copay and a painful one. Know your formulary before your physician writes the prescription.
Use MedSwitcher's comparison tools to check your UHC plan's GLP-1 coverage, compare alternatives, and find the most cost-effective medication for your situation.
Sources
- UnitedHealthcare pharmacy benefit information, 2026.
- OptumRx formulary and clinical policy guidelines, Q1 2026.
- UHC Clinical Coverage Guidelines: Anti-Obesity Medications.
- American Diabetes Association Standards of Care, 2026.
- MedSwitcher insurance coverage database, updated April 2026.